KhalidMumtazMDMSc (clinical epidemiology)

Gastroenterology • Columbus, OH

Hepatology & Liver Transplantation

Associate Professor

Join to view full profile

Dr. Mumtaz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mumtaz's full profile

Already have an account?

Office
410 W 10th Ave
Columbus, OH 43210
Phone+1 614-293-6255

Fax+1 614-293-8518

Education & Training

Dow University of Health SciencesClass of 1993

Certifications & Licensure

OH State Medical License 2014 - 2023

Publications & Presentations

PubMed

Impact of social vulnerability index on patients with alcohol-related liver disease.
Ayushi Jain, Michael R Wellner, Jing Peng, Jianing Ma, Kenneth D Allen
Alcohol. 2024-12-01
4 citations
Impact of GLP-1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol-Associated Liver Disease and Type 2 Diabetes.
Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Sidharth Iyer, Muhammad Muntazir Mehdi Khan
Liver International. 2024-10-15
7 citations
Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease ci...
Mohamed I Elsaid, Na Li, Stephen A Firkins, Vinod K Rustgi, Electra D Paskett
Alimentary Pharmacology & Therapeutics. 2024-05-01

Press Mentions

Pandemic Drinking Triggers Surge in Liver TransplantsAugust 5th, 2021
Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024
Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024